Tumor specific CD8+ T cells in patients with lung cancer and healthy individuals.


Lung cancer, one of the leading causes of cancer death in the developed world, presents with a poor 5-year survival, despite improvements in conventional treatments such as surgery, radiotherapy and chemotherapy. Lung cancer-directed immunotherapy promises to harness the body's ability to mount antitumor immune responses and destroy cancer cells. Improving… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.